Webinar

Biologic Comparison of Inhaled Insulin DPI to Exubera™

Format: External webinar | Document type: Webinar

Biologic Comparison of Inhaled Insulin DPI to Exubera™
Inhaled peptides and proteins have promise for respiratory and systemic disease treatment such as diabetes. This class of molecules is particularly well suited to formulation and processing by spray drying to achieve respirable engineered particles. This webinar will discuss important aspects of formulation and process development for an inhaled biotherapeutic. Specifically, it will discuss pharmacokinetic and pharmacodynamic performance after pulmonary delivery of a DPI, via a recent case study comparing the inhalation performance of a novel spray-dried powder of insulin to Exubera™.

Speakers

David Vodak, Ph.D. David Vodak, Ph.D. Vice President of Chemistry
Bend Research, part of Capsugel Dosage Form Solutions

Philip Kuehl, Ph.D. Philip Kuehl, Ph.D. Research Scientist
Lovelace Respiratory Research Institute

Related resources from Capsugel

Supplier info centre